These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis. Kaplan MM Semin Liver Dis; 1997 May; 17(2):129-36. PubMed ID: 9170200 [TBL] [Abstract][Full Text] [Related]
6. [Primary biliary cirrhosis]. Kuiper EM; den Ouden-Muller JW; van Buuren HR Ned Tijdschr Geneeskd; 2009; 153():A483. PubMed ID: 19900324 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate. Lee YM; Kaplan MM Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960 [TBL] [Abstract][Full Text] [Related]
14. Primary biliary cirrhosis: how should we evaluate new treatments? Goddard CJ; Warnes TW Lancet; 1994 May; 343(8909):1305-6. PubMed ID: 7910318 [No Abstract] [Full Text] [Related]
15. Medical treatment of primary biliary cirrhosis. Kaplan MM Semin Liver Dis; 1989 May; 9(2):138-43. PubMed ID: 2658104 [No Abstract] [Full Text] [Related]
16. Treatment of primary biliary cirrhosis. Poupon R; Poupon RE Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):615-28. PubMed ID: 10976018 [TBL] [Abstract][Full Text] [Related]
17. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid. Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198 [TBL] [Abstract][Full Text] [Related]